OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Psychiatry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	632
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	627
Establishment of Best Practices for Evidence for Prediction	414
Internet-Based Cognitive Behavioral Therapy for Depression	410
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	384
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	341
Association Between Physical Activity and Risk of Depression	298
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	291
Prevention of Psychosis	286
How COVID-19 Affects the Brain	285
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	251
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	240
Battling the Modern Behavioral Epidemic of Loneliness	224
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	219
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	214
From Basic Science to Clinical Application of Polygenic Risk Scores	192
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	170
Could Polygenic Risk Scores Be Useful in Psychiatry?	160
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	160
Psychosocial Interventions and Immune System Function	156
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	154
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	152
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	152
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	151
Probability of Transition to Psychosis in Individuals at Clinical High Risk	151

Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	151
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	150
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	149
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	146
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	143
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	140
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	135
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	132
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	124
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	123
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	122
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	122
Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder	119
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	117
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	116
The Current Status of Psychedelics in Psychiatry	116
Adjunctive Psychotherapy for Bipolar Disorder	115
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	114
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	113
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	106
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	105
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	104
Effect of Zuranolone vs Placebo in Postpartum Depression	104
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women	103
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	103
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	102
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	100
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	99
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	99
Male and Female Physician Suicidality	97
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	97
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	97
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	96
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	95
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	94
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	93
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	91
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	90
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	87
National Trends in Mental Health Care for US Adolescents	86
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	85
Association of Cannabis Use During Adolescence With Neurodevelopment	84
Association of Drug Cues and Craving With Drug Use and Relapse	84
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders	83
All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids	80
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	80
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	79
Social Isolation and Loneliness in Older Adults—A Mental Health/Public Health Challenge	76
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	76

Applying Causal Inference Methods in Psychiatric Epidemiology	74
Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons	74
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis	74
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	73
Suicide Prevention in the COVID-19 Era	73
Association of Mental Disorder in Childhood and Adolescence With Subsequent Educational Achievement	72
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features	72
Association Between Ambient Heat and Risk of Emergency Department Visits for Mental Health Among US Adults, 2010 to 2019	71
Effectiveness of Task-Shifted Trauma-Focused Cognitive Behavioral Therapy for Children Who Experienced Parental Death and Posttraumatic Stress in Kenya and Tanzania	71
Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms	71
Prediction, Not Association, Paves the Road to Precision Medicine	70
Association of US Nurse and Physician Occupation With Risk of Suicide	70
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	69
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	68
Emergency Department Encounters Among Youth With Suicidal Thoughts or Behaviors During the COVID-19 Pandemic	67
Contingency Management for Patients Receiving Medication for Opioid Use Disorder	67
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	67
Association of Screen Time With Internalizing and Externalizing Behavior Problems in Children 12 Years or Younger	67
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia	66
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019	66
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment	65
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	65
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic	64
Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety	64
Stratified Care vs Stepped Care for Depression	63
Associations Between Depression, Arterial Stiffness, and Metabolic Syndrome Among Adults in the UK Biobank Population Study	61
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia	60
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	58
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?	58
Association of Hypothyroidism and Clinical Depression	57
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects	56
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence	56
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries	56
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia	56
Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals	55
Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder	54
Multimodal Categorical and Dimensional Approaches to Understanding Threat Conditioning and Its Extinction in Individuals With Anxiety Disorders	54
Outcomes of Randomized Clinical Trials of Interventions to Enhance Social, Emotional, and Spiritual Components of Wisdom	53
Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals	53
Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation	52
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder	52
Meeting Maternal Mental Health Needs During the COVID-19 Pandemic	51
Preaddiction—A Missing Concept for Treating Substance Use Disorders	51
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	51
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	51
Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder	51
Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic	50
Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017	50
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment	50
A Development Pathway Towards Precision Mental Health Care	50
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness	49
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness	49
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People	49
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	48
Suicide Prevention Research Priorities in Health Care	48
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US	48
Cost-effectiveness of Treatments for Opioid Use Disorder	48
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	48
Longitudinal Associations of Mental Disorders With Dementia	47
Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function	47
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	47
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	47
Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder	47
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder	47
Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015	47
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	47
Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits	47
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder	47
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	47
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population	46
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	45
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	45
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia	45
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails	44
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	44
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care	44
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	44
Use of Medications for Alcohol Use Disorder in the US	44
Religious Service Attendance and Deaths Related to Drugs, Alcohol, and Suicide Among US Health Care Professionals	43
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark	43

Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	43
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	43
Why Deaths of Despair Are Increasing in the US and Not Other Industrial Nations—Insights From Neuroscience and Anthropology	43
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals	43
The Loss of Social Connectedness as a Major Contributor to Physician Burnout	42
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	42
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions	42
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia	41
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	41
Preparing for the Bursting of the Psychedelic Hype Bubble	41
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	41
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders	41
Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia	41
An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings	41
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	41
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression	41
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults	41
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	41
Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US	40
Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence and Their Implications for Psychiatric Disorders	40
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	40
Race as a Social Construct in Psychiatry Research and Practice	40
Current Epidemiological Trends in Firearm Mortality in the United States	39
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries	39
Driving Performance and Cannabis Users’ Perception of Safety	39
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder	39
Going Upstream to Advance Psychosis Prevention and Improve Public Health	39
Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder	39
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia	39
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	39
Association of Nondiscrimination Policies With Mental Health Among Gender Minority Individuals	38
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	38
Removing the Reliability Bottleneck in Functional Magnetic Resonance Imaging Research to Achieve Clinical Utility	37
Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals	37
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients	37
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death	36
Association of History of Psychopathology With Accelerated Aging at Midlife	36
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands	36
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US	36
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	35
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	35
Changes Over Time in the Differential Mortality Gap in Individuals With Mental Disorders	35
Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder	35
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia	35
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19	35
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder	35
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	35
A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders	34
Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores	34
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status	33
Pragmatic Precision Psychiatry—A New Direction for Optimizing Treatment Selection	33
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry	33
Socioeconomic Indicators of Treatment Prognosis for Adults With Depression	33
Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya	33
Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample	33
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months	33
Effectiveness of a Guided Web-Based Self-help Intervention to Prevent Depression in Patients With Persistent Back Pain	33
Changes and Inequities in Adult Mental Health–Related Emergency Department Visits During the COVID-19 Pandemic in the US	33
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection	32
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	32
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	32
Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count	32
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression	32
Association of Borderline Personality Disorder Criteria With Suicide Attempts	31
Prevalence of Perinatal Depression in Low- and Middle-Income Countries	31
Effect of Online 1-Day Cognitive Behavioral Therapy–Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression	31
Structural Magnetic Resonance Imaging All Over Again	31
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States	31
Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic	31
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	30
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia	30
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	30
Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation	30
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care	29
Association of Early-Life Mental Health With Biomarkers in Midlife and Premature Mortality	29
Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data	29
Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems	29
Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis	29
Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults	29
The Origin of Our Modern Concept of Depression—The History of Melancholia From 1780-1880	28
Tapering Antipsychotic Treatment	28
Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms	28
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study	28
Psychedelic Drug Legislative Reform and Legalization in the US	27
Individual Differences in Response to Antidepressants	27
Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders	27
Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China	26
Effect of Matching Therapists to Patients vs Assignment as Usual on Adult Psychotherapy Outcomes	26
Social Determinants of Mental Health	26
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	26
Long-term Exposure to Multiple Ambient Air Pollutants and Association With Incident Depression and Anxiety	26
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	26
Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples	26
Association of Insulin Resistance With Depression Severity and Remission Status	26
Individual Differences in Response to Antidepressants	25